Citadel Advisors’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.46M Buy
182,346
+110,471
+154% +$1.49M ﹤0.01% 2505
2025
Q1
$622K Buy
71,875
+30,826
+75% +$267K ﹤0.01% 3764
2024
Q4
$199K Sell
41,049
-34,729
-46% -$169K ﹤0.01% 4898
2024
Q3
$585K Sell
75,778
-26,675
-26% -$206K ﹤0.01% 3640
2024
Q2
$1.02M Buy
102,453
+50,252
+96% +$503K ﹤0.01% 3010
2024
Q1
$634K Sell
52,201
-60,044
-53% -$730K ﹤0.01% 3643
2023
Q4
$1.61M Buy
112,245
+59,206
+112% +$847K ﹤0.01% 2592
2023
Q3
$413K Sell
53,039
-37,442
-41% -$291K ﹤0.01% 3961
2023
Q2
$1.29M Sell
90,481
-98,104
-52% -$1.4M ﹤0.01% 2762
2023
Q1
$2.76M Buy
188,585
+31,409
+20% +$460K ﹤0.01% 2260
2022
Q4
$2.64M Buy
157,176
+58,498
+59% +$983K ﹤0.01% 2333
2022
Q3
$1.46M Buy
+98,678
New +$1.46M ﹤0.01% 3048
2022
Q2
Sell
-52,488
Closed -$1.98M 6664
2022
Q1
$1.98M Buy
+52,488
New +$1.98M ﹤0.01% 3020
2021
Q4
Sell
-12,192
Closed -$1.04M 6951
2021
Q3
$1.04M Sell
12,192
-5,935
-33% -$508K ﹤0.01% 3733
2021
Q2
$1.12M Buy
18,127
+11,103
+158% +$687K ﹤0.01% 3879
2021
Q1
$342K Sell
7,024
-20,744
-75% -$1.01M ﹤0.01% 4907
2020
Q4
$865K Buy
+27,768
New +$865K ﹤0.01% 3388